Analyst Ratings for Adeptus Biotechnologies Corp. (ADPT) [Neutrals]
ADPT Rating Summary
ADPT Price Target Summary
- Highest: $14.00 (Piper Sandler)
- Lowest: $5.00 (Goldman Sachs)
- Average: $8.71
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$8.71 (+235.2%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 75%
Avg. $ Target:
$8.71 (+235.2%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/3/2021 | Goldman Sachs » Updated 2/16/2024 |
Salveen Richter | Downgrade | Neutral (Buy) |
5.00 (11.00) |
53.11 (2.60) |
-95.1% | Details |
| 9/9/2020 | Morgan Stanley » Updated 10/24/2023 |
Tejas Savant | New Coverage | Equalweight (N/A) |
10.00 (13.00) |
35.79 (2.60) |
-92.74% | Details |
 |
||||||||
|
||||||||
